0
Abstract: Poster Presentations |

THE ROLE OF FOXO1(FKHR) IN APOPTOSIS OF NON-SMALL CELL LUNG CANCER (NSCLC) FREE TO VIEW

Takayo Maekawa, MD*; Yoshimasa Maniwa, MD; Masahiro Yoshimura, MD; Takefumi Doi; Yoshitake Hayashi, MD; Yutaka Okita, MD
Author and Funding Information

Kobe University Graduate School of Medicine, Kobe, Japan



Chest. 2006;130(4_MeetingAbstracts):234S. doi:10.1378/chest.130.4_MeetingAbstracts.234S-a
Text Size: A A A
Published online

Abstract

PURPOSE: FOXO1(FKHR), one of the Forkhead family of transcription factors, is involved in pro-apoptotic signaling. Phosphorylated Akt/PKB leads to the inhibition of FOXO1 activity by phosphorylation and cytoplasmic sequestration. In this study, we examined the role of FOXO1 in apoptosis of non-small cell lung cancer (NSCLC) cells.

METHODS: Localization of FOXO1 was examined by fluorescent immunohistochemistry on three different NSCLC cell lines (A549, EBC1,and PC3). Akt/PKB was knocked down by the RNA interference method to examine the relationship between Akt/PKB expression and FOXO1 status. Furthermore, TUNEL staining was performed to identify the induction of apoptosis in these cells.

RESULTS: FOXO1 was sequestered from the nucleus in all three cell lines cultured with fetal bovine serum (FBS), while without FBS, nuclear inclusion of FOXO1 was observed. Inhibition of Akt/PKB resulted in the accumulation of FOXO1 in the nucleus of A549 and EBC1, in which, induction of apoptosis was accelerated.

CONCLUSION: FOXO1 is constitutively present in the cytoplasm in NSCLC cells, and inhibition of Akt/PKB induces its translocation to the nucleus, leading to apoptosis.

CLINICAL IMPLICATIONS: Further investigations could yield novel molecular targeted treatment strategies for non-small cell lung cancer aimed at inhibiting the Akt/PKB-FOXO1 signaling pathway.

DISCLOSURE: Takayo Maekawa, None.

Wednesday, October 25, 2006

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543